|
Zinc dysregulation as a druggable target in human skin photocarcinogenesis
|
1R03CA230949-01
|
$73,677
|
|
WONDRAK, GEORG
|
UNIVERSITY OF ARIZONA
|
|
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral Mechanisms
|
5R01CA181064-02
|
$625,440
|
$625,440
|
MUSTIAN, KAREN
|
UNIVERSITY OF ROCHESTER
|
|
Yoga for women with breast cancer undergoing radiotherapy
|
5R01CA138800-06
|
$725,391
|
$725,391
|
COHEN, LORENZO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-36S1
|
$125,000
|
$1,250
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-36
|
$2,600,006
|
$26,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$531,469
|
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-02
|
$318,936
|
$318,936
|
PIRL, WILLIAM
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-03
|
$2,539,856
|
$2,539,856
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
5P50CA211024-02
|
$2,283,108
|
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Weight cycling and total and site-specific cancer incidence and mortality
|
5R03CA204825-02
|
$79,500
|
|
GIOVANNUCCI, EDWARD
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
5F31CA213901-02
|
$44,524
|
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-02
|
$3,690,620
|
$3,690,620
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Virtual Weight Loss Program for African-American Breast Cancer Survivors
|
1R21CA191431-01A1
|
$207,495
|
$207,495
|
FERRANTE, JEANNE
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
|
Vermont Breast Cancer Molecular Characterization Laboratory
|
5U01CA196383-04
|
$312,000
|
|
STEIN, JANET
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Vegetable garden feasibility trial to promote function in older cancer survivors
|
5R21CA182508-02
|
$158,646
|
$158,646
|
DEMARK-WAHNEFRIED, WENDY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-03
|
$341,981
|
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,186,781
|
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-02
|
$675,649
|
$675,649
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Validation of PROMIS Measures in Children with Brain Tumors
|
5R01CA174452-04
|
$309,251
|
$309,251
|
LAI, JIN-SHEI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases
|
2R42CA206744-02A1
|
$665,919
|
|
MCCABE, AARON
|
MINNETRONIX, INC.
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
4UH3CA206124-03
|
$423,750
|
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
5P01CA154291-04
|
$3,698,322
|
$776,648
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$532,008
|
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$532,008
|
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$749
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$85,770
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
|
1K99CA230384-01
|
$107,860
|
|
HOPKINS, BENJAMIN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Utilizing Nucleic-Acid Scavengers to Ameliorate Inflammation-driven Metastatic Progression in Breast Cancer
|
1F31CA232394-01
|
$35,885
|
|
ETESHOLA, ELIAS
|
DUKE UNIVERSITY
|
|
Using the RE-AIM Model to Translate Distress Screening into Cancer Care
|
5R25CA177553-03
|
$275,855
|
$275,855
|
MCCORKLE, RUTH
|
YALE UNIVERSITY
|
|
Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors
|
5R01CA166084-03
|
$323,796
|
$323,796
|
HERSHMAN, DAWN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients
|
5R01CA193706-03
|
$554,574
|
$554,574
|
WYATT, GWEN
|
MICHIGAN STATE UNIVERSITY
|
|
Using patient-derived models to understand drug responses in SCLC
|
1U01CA220323-01A1
|
$619,923
|
|
DYSON, NICHOLAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
2R42CA168107-02
|
$616,412
|
$616,412
|
MCLAUGHLIN, JEFFERY
|
RADIANT CREATIVE GROUP, LLC
|
|
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy Women
|
1K07CA221899-01A1
|
$129,704
|
|
GUNN, CHRISTINE
|
BOSTON MEDICAL CENTER
|
|
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
|
5K07CA160722-05
|
$170,100
|
$170,100
|
SANOFF, HANNA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Urinary Diversion Among Bladder Cancer Survivors: Cost, Complications, and QOL
|
5R01CA164128-04
|
$610,181
|
$610,181
|
MCMULLEN, CARMIT
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
5U54CA096300-13
|
$1,056,847
|
$169,096
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Texas PDX Development and Trial Center
|
3U54CA224065-01S1
|
$175,000
|
|
ROTH, JACK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-27S1
|
$198,450
|
$5,954
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-27
|
$6,097,616
|
$182,928
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-16S1
|
$114,745
|
$34,424
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-16S3
|
$177,700
|
$53,310
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-16
|
$1,361,692
|
$408,508
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S5
|
$1,213,480
|
$12,135
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S6
|
$48,256
|
$483
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
|
1U54CA233306-01
|
$6,160,778
|
|
PAN, CHONG-XIAN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Uniting Mass Spectrometry and Glycoscience to Investigate Cancer Biology
|
4K00CA212454-03
|
$71,550
|
|
RILEY, NICHOLAS
|
STANFORD UNIVERSITY
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
3R01CA181633-05S1
|
$69,420
|
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding Treatment Tolerability in Older Patients with Cancer
|
1U01CA233167-01
|
$649,295
|
|
MOHILE, SUPRIYA
|
UNIVERSITY OF ROCHESTER
|
Total relevant funding to Cancer Survivorship for this search: $207,708,080
|